The DOI matches its OpenAlex record; 28 of the 28 references it cites were found in a registry or an index.
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines
Abstract
It has been suggested that vitamin D deficiency may promote prostate cancer, although the mechanism is not understood. In this study three human prostate carcinoma cell lines, LNCaP, DU-145, and PC-3, were examined both for the presence of specific 1,25 dihydroxyvitamin D3 [1,25(OH)2D3] receptors (VDRs) and also employed to study the effects of hormone on cell proliferation and differentiation. Ligand binding experiments demonstrated classical VDR in all three cell lines examined with an apparent dissociation constant of 7.5, 5.4, and 6.3 x 10(-11) M for LNCaP, DU-145, and PC-3 cells, respectively. Corresponding binding capacity for the three prostate carcinoma cell lines were 27, 31, and 78 fmol/mg protein, respectively. The presence of VDR in the three cell lines was also confirmed by immunocytochemistry. In addition, one major 4.6-kilobase messenger RNA transcript hybridizing with a specific human VDR complementary DNA probe was identified in all three cell lines. Interestingly, both DU-145 and PC-3 but not LNCaP cell lines exhibited 1,25(OH)2D3-stimulated induction of 24-hydroxylase messenger RNA employed as a marker of 1,25(OH)2D3 action. Physiological levels of 1,25(OH)2D3 dramatically inhibited proliferation of the LNCaP and PC-3 cell lines. However, in spite of the presence of high affinity VDR, proliferation of DU-145 cells was not inhibited by 1,25(OH)2D3 at the doses tested. Treatment with 1,25(OH)2D3 caused a dose-dependent stimulation of prostate-specific antigen secretion by LNCaP cells. In conclusion, these results demonstrate that these three human prostate carcinoma cell lines all possess specific VDR and that 1,25(OH)2D3 treatment can elicit both an antiproliferative and a differentiating action on these cancer cells. The findings lend support to the hypothesis that vitamin D might exert beneficial actions on prostate cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
AUFFRAY, C., & ROUGEON, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,627
Cloning and expression of full-length cDNA encoding human vitamin D receptor.
Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., & O'Malley, B. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3294 · Cited by 959
NORMAN, A. W., ROTH, J., & ORCI, L. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-4-331 · Cited by 703
SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY
Garland, C., Garland, F., Shaw, E., Comstock, G., Helsing, K., & Gorham, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91789-3 · Cited by 678
Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).
Schwartz, G. G., & Hulka, B. S. (1990) · PubMed · Cited by 508
Repression of c- fos Transcription and an Altered Genetic Program in Senescent Human Fibroblasts
Seshadri, T., & Campisi, J. (1990) · Science · doi:10.1126/science.2104680 · Cited by 481
Kerner, S. A., Scott, R. A., & Pike, J. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4455 · Cited by 405
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study.
Hsing, A. W., McLaughlin, J. K., Schuman, L. M., Bjelke, E., Gridley, G., Wacholder, S., Chien, H. T. C., & Blot, W. J. (1990) · PubMed · Cited by 348
Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.
Eisman, J. A., Barkla, D. H., & Tutton, P. J. M. (1987) · PubMed · Cited by 309
Cloning and expression of cDNA encoding 25‐hydroxyvitamin D3 24‐hydroxylase
Ohyama, Y., Noshiro, M., & Okuda, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80115-j · Cited by 233
Gleave, M. E., Hsieh, J. T., Wu, H. C., von Eschenbach, A. C., & Chung, L. W. K. (1992) · PubMed · Cited by 226
Stamey, T. A., Kabalin, J. N., & Ferrari, M. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)41176-1 · Cited by 224
Immunocytochemical Localization of the 1,25-Dihydroxyvitamin D3Receptor in Target Cells*
CLEMENS, T. L., GARRETT, K. P., ZHOU, X.-Y., PIKE, J. W., HAUSSLER, M. R., & DEMPSTER, D. W. (1988) · Endocrinology · doi:10.1210/endo-122-4-1224 · Cited by 204
Immunocytochemical Detection of 1,25-Dihydroxyvitamin D Receptors in Normal Human Tissues*
BERGER, U., WILSON, P., McCLELLAND, R. A., COLSTON, K., HAUSSLER, M. R., PIKE, J. W., & COOMBES, R. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-607 · Cited by 196
Malloy, P. J., Hochberg, Z., Tiosano, D., Pike, J. W., Hughes, M. R., & Feldman, D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114944 · Cited by 193
Self-citationDietary beta-carotene and cancer of the prostate: a case-control study in Kyoto, Japan.
Ohno, Y., Yoshida, O., Oishi, K., Okada, K., Yamabe, H., & Schroeder, F. H. (1988) · PubMed · Cited by 167
1,25-Dihydroxyvitamin D3Receptors and Hormonal Responses in Cloned Human Skeletal Muscle Cells*
COSTA, E. M., BLAU, H. M., & FELDMAN, D. (1986) · Endocrinology · doi:10.1210/endo-119-5-2214 · Cited by 165
Self-citationChen, T. L., Hauschka, P. V., Cabrales, S. X., & Feldman, D. (1986) · Endocrinology · doi:10.1210/endo-118-1-250 · Cited by 108
Self-citationVitamin D: A modulator of cell proliferation and differentiation
Pols, H. A. P., Birkenhäger, J. C., Foekens, J. A., & van Leeuwen, J. P. T. M. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90435-n · Cited by 105
Zhao, X.-Y., & Feldman, D. (1993) · Endocrinology · doi:10.1210/endo.132.4.8384998 · Cited by 99
Self-citationPike, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43583-6 · Cited by 91
Malloy, P. J., Hochberg, Z., PIKE, J. W., et al. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-263 · Cited by 90
The role of diet in prostate cancer
Kaul, L., Heshmat, M. Y., Kovi, J., Jackson, M. A., Jackson, A. G., Jones, G. W., Edson, M., Enterline, J. P., Worrell, R. G., & Perry, S. L. (1987) · Nutrition and Cancer · doi:10.1080/01635588709513919 · Cited by 71
Schleicher, G. K., Privette, T. H., & Stumpf, W. E. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.7.2543697 · Cited by 52
Possible significance of new target tissues for 1,25-dihydroxyvitamin D3
Walters, M. R., CUNEO, D. L., & JAMISON, A. P. (1983) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(83)90034-1 · Cited by 49
Chen, T. L., & Feldman, D. I. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90990-8 · Cited by 44
Self-citationVenkatesh (1989) · doi:10.1002/1097-0142(19890801)64:3
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
The role of vitamin D in reducing cancer risk and progression
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E., & Feldman, B. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3691 · Cited by 1,311
Self-citationNoncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
Ahonen, M. H., Tenkanen, L., Teppo, L., Hakama, M., & Tuohimaa, P. (2000) · Cancer Causes & Control · doi:10.1023/a:1008923802001 · Cited by 494
Metadata
- Authors
- Skowroński, R., Peehl, D. M., & Feldman, D. I.
- Venue
- Endocrinology
- Publisher
- Oxford University Press
- Published
- 1993-05-01
- Volume
- 132
- Issue
- 5
- Pages
- 1952-1960
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W1986527803
- Cited by
- 494
- References
- 28
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.